Get In Touch
ArchAngel MLD Trust,
506 Betula House, North Wharf
Road, London, W2 1DT
Work Inquiries
Contact@ArchAngel.org.uk
Registered Charity Number 1157825

ArchAngel
MLD Trust

ArchAngel MLD Trust is a registered charity dedicated to improving the health outcomes of those affected by the rare genetic illness Metachromatic Leukodystrophy.

About Us

What we do at ArchAngel MLD Trust

Metachromatic Leukodystrophy (MLD) is a life-limiting illness which affects around 1 in every 100,000 people. It is caused by a lack of the ARSA enzyme in the patient’s metabolic system and is classified as a ‘demyelinating illness’ (leukodystrophy), a ‘lysosomal storage disorder’ (LSD) and an ‘Inherited Metabolic Disorder’ (IMD).

Icon
Supporting Global Medical Teams

We support medical teams worldwide who are working to help people with MLD, providing essential resources, support to clinicians and scientific researchers.

Icon
Advocating for Newborn Screening

We are coordinating the application to have MLD added to the UK newborn bloodspot test, ensuring future MLD babies have access to life-saving treatment.

Icon
Awarding Grants for UK Families

We award private grants to UK families with children affected by MLD, including for specialist equipment, physical therapies and essential caregiver support.

Icon
Advancing Treatments

We promote and support advances in gene therapy and enzyme replacement technologies, providing hope and potential new treatment options for future MLD patients.

About Us

What we do at ArchAngel MLD Trust

archangel-about
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus lacinia odio vitae vestibulum vestibulum. Cras venenatis euismod malesuada, non laoreet.
Supporting Global Medical Teams

We support medical teams worldwide to help people with the rare genetic illness MLD, providing essential medical support and resources.

Advocating for Newborn Screening

We lead efforts to include MLD in the UK newborn bloodspot test, ensuring future MLD babies have access to life-saving treatment.

Awarding Grants for UK Families

We awards private grants to UK families with children affected by MLD, offering financial assistance and support.

Advancing Gene Therapy

We promote and support advancements in gene therapy research, providing hope and new treatment options for those affected by MLD.

Our Inspiration

Ava’s Story

ArchAngel MLD Trust was inspired by a little girl named Ava, who was diagnosed with MLD at six years old in 2013. Faced with this devastating diagnosis and no treatment options in the UK, her family sought help globally and discovered the San Raffaele Telethon Institute in Milan, Italy. Ava became the 12th child in the world to participate in a groundbreaking gene therapy trial, which aimed to correct her faulty DNA using her own stem cells. The therapy was successful, altering the predicted course of her disease. Ava’s journey not only brought new hope to her family but also paved the way for the approval and wider use of this life-saving treatment. In 2021 the treatment, now known as ‘Libmeldy’, was approved for use by NHS England, offering a beacon of hope to other families affected by MLD.

Every child counts, no matter how rare their condition. Thank you for your support.

What is the ArchAngel MLD Trust?

Icon
Founding and Inspiration

The ArchAngel MLD Trust was founded in 2014 by Ava’s family and family friends in their desire to help others facing this rare and terminal illness.

Icon
Trustees

The Trust is an unincorporated association governed by a constitution, Registered Charity Number 1157825. All Trustees are personally connected to MLD and are unpaid volunteers.

Icon
Fundraising Goals

The Trust makes grants to organizations engaged in MLD research; awards private grants to individual families and is leading efforts in newborn screening (NBS). We are actively raising funds for our popular grant programme and vital NBS work.

Icon
Grants for Families

ArchAngel awards private grants to individual families. ArchAngel has helped numerous UK families purchase wheelchairs, bicycles, breathing apparatus, sensory toys, physiotherapy sessions, home adaptations, and respite care.

Icon
Newborn Screening Work

Early diagnosis is crucial, and detecting MLD at birth could save lives. ArchAngel is coordinating the work required to include MLD in the UK’s Newborn Bloodspot (NBS) Screening Programme.